Remarkably, we show that increased sEV‐PD‐L1 in patients’ plasma samples is associated with improved GvHD after clinical WJMSC infusion, suggesting that sEV‐PD‐L1 is an important mechanism explaining the efficacy of WJMSC in aGvHD patients. Here, CD274 is linked to graft versus host disease.